iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/24807341
Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;123(6):1201-1206.
doi: 10.1097/AOG.0000000000000286.

Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery

Jennifer M Wu  1 , Catherine A Matthews, Mitchell M Conover, Virginia Pate, Michele Jonsson Funk
Affiliations

Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery

Jennifer M Wu et al. Obstet Gynecol. 2014 Jun.

Abstract

Objective: To estimate the lifetime risk of stress urinary incontinence (SUI) surgery, pelvic organ prolapse (POP) surgery, or both using current, population-based surgical rates from 2007 to 2011.

Methods: We used a 2007-2011 U.S. claims and encounters database. We included women aged 18-89 years and estimated age-specific incidence rates and cumulative incidence (lifetime risk) of SUI surgery, POP surgery, and either incontinence or prolapse surgery with 95% confidence intervals (CIs). We estimated lifetime risk until the age of 80 years to be consistent with prior studies.

Results: From 2007 to 2011, we evaluated 10,177,480 adult women who were followed for 24,979,447 person-years. Among these women, we identified 65,397 incident, or first, SUI and 57,755 incident prolapse surgeries. Overall, we found that the lifetime risk of any primary surgery for SUI or POP was 20.0% (95% CI 19.9-20.2) by the age of 80 years. Separately, the cumulative risk for SUI surgery was 13.6% (95% CI 13.5-13.7) and that for POP surgery was 12.6% (95% CI 12.4-2.7). For age-specific annual risk, SUI demonstrated a bimodal peak at age 46 years and then again at age 70-71 years with annual risks of 3.8 and 3.9 per 1,000 women, respectively. For POP, the risk increased progressively until ages 71 and 73 years when the annual risk was 4.3 per 1,000 women.

Conclusion: Based on a U.S. claims and encounters database, the estimated lifetime risk of surgery for either SUI or POP in women is 20.0% by the age of 80 years.

Level of evidence: III.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-specific annual risk (per 1,000 women) of surgery for stress urinary incontinence (SUI), pelvic organ prolapse (POP), or either SUI or POP surgery with 95% confidence intervals (CI).
Figure 2
Figure 2
Cumulative incidence, or lifetime risk, of surgery for stress urinary incontinence (SUI), pelvic organ prolapse (POP), or SUI or POP surgery from age 18 years through age 84 years. The width of the lines represents the 95% confidence interval (CI) of the cumulative incidence at each age. The cumulative incidence (95% CI) by age 80 per 1,000 women was 200.1 (95% CI 198.7–201.5) for SUI or POP, 135.9 (95%CI 134.8–137.1) for SUI only, and 125.6 (95% CI 124.4–126.7) for POP only.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008 Sep 17;300(11):1311–6. - PMC - PubMed
    1. FDA. 510(K) Number K974098. 1998 Jan 28; Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/K974098.pdf. Retrieved on December 10, 2013.
    1. FDA Safety Communication. Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Issued on July 13, 2011. Available at: http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm. Retrieved on December 10, 2013.
    1. Jonsson Funk M, Levin PJ, Wu JM. Trends in the surgical management of stress urinary incontinence. Obstet Gynecol. 2012 Apr;119(4):845–51. - PMC - PubMed
    1. Jonsson Funk M, Edenfield AL, Pate V, Visco AG, Weidner AC, Wu JM. Trends in use of surgical mesh for pelvic organ prolapse. Am J Obstet Gynecol. 2013 Jan;208(1):79.e1–7. - PMC - PubMed

Publication types